Kam et al. have shown that intravenous irisin delivery via viral vectors following intrastriatal injection of α-synuclein preformed fibrils in mouse models of PD reduces pathological α-synuclein accumulation, preserves dopamine neurons, prevents striatal dopamine depletion, and improves motor deficits136. This evidence concerns the gene SNCA and Parkinson disease.